In this EyewireTV Episode
04.01.20
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
VIEW MORE
Eyewire TV Archive
- Watch Episode
- OR SELECT A SEGMENT
- Eyewire TV May 27th 2020
- BMC Virtual Spring Symposium to Take Place This Weekend | 1:36
- Mass. Eye and Ear Develops Novel Gene-Based COVID-19 Vaccine Candidate | 4:26
- Port Delivery System With Ranibizumab Shows Positive Phase 3 Results in Wet AMD | 1:04
- Conclusion | 0:10
- Watch Episode
- OR SELECT A SEGMENT
- Eyewire TV May 20th 2020
- Alcon ARGOS Biometer With Image Guidance Now Widely Available in the US | 1:17
- Johnson & Johnson Vision Announces US Launch of the Tecnis Multifocal Toric II IOL | 1:30
- Avellino's ACTS Program to Help Protect Patients and Staff From COVID-19 | 2:45
- Ocutrx Unveils OR-Bot Surgery Visualization Theatre | 1:21
- BVI Acquires Ophthalmic Viscoelastic Device Assets From Croma | 1:00
- Conclusion | 0:10
- Watch Episode
- OR SELECT A SEGMENT
- Eyewire TV May 13th 2020
- COVID-19 Analysis: Ophthalmology Lost More Patient Volume Than Any Other Specialty | 1:55
- FDA Approves Quidel’s Sofia 2, First Antigen Test to Help in the Detection of COVID-19 | 1:16
- AbbVie Completes $63 Billion Acquisition of Allergan | 1:23
- Sight Sciences Introduces the Next-Generation Omni Surgical System for MIGS | 1:00
- Oyster Point Announces Phase 3 Trial Results of Nasal Spray for Dry Eye Disease | 3:01
- Conclusion | 0:10
- Watch Episode
- OR SELECT A SEGMENT
- Eyewire TV May 6th 2020
- AAO Surveys Reveal the Effect COVID-19 is Having On Ophthalmology Practices | 2:03
- Leaders of Ophthalmic Medical Societies Provide Updates on Annual Meetings | 8:10
- The FDA Issues an Emergency Use Authorization For a Potential COVID-19 Treatment | 1:18
- Kala Pharmaceuticals Resubmits NDA For Dry Eye Drug Candidate Eysuvis | 1:18
- Conclusion | 0:10
- Watch Episode
- OR SELECT A SEGMENT
- Eyewire TV April 29th 2020
- AAO, ASCRS, and OOSS Develop Checklist for Reopening Ophthalmic Surgery Centers | 1:58
- Experts Discuss Impact of COVID-19 On Residents and Training Programs | 3:31
- Ocular Therapeutix Announces Phase 3 Data of Dextenza for Allergic Conjunctivitis | 2:59
- New Dates Announced for BMC Virtual Spring Symposium | 1:20
- Conclusion | 0:10
- Watch Episode
- OR SELECT A SEGMENT
- Eyewire TV April 22nd 2020
- BMC to Host First Virtual Spring Symposium in May | 2:20
- CMS Releases New Guidance on Restarting Elective Procedures | 1:38
- AAO Addresses Reopening of Ophthalmology Care | 2:52
- Ophthalmic Companies Devote Resources to Assist Eye Care Professionals and Patients During COVID-19 | 3:40
- Conclusion | 0:10